INTERNATIONAL PATENT: CHANGCHUN GENESCIENCE PHARMACEUTICAL CO., LTD., 长春金赛药业有限责任公司 FILES APPLICATION FOR "FIBROBLAST GROWTH FACTOR RECEPTOR INHIBITOR, PHARMACEUTICAL COMPOSITION AND USE THEREOF"

GENEVA, Feb. 3 -- CHANGCHUN GENESCIENCE PHARMACEUTICAL CO., LTD. (1718 Yueda Road, Changchun High-Tech Dev. ZoneChangchun, Jilin 130012), 长春金赛药业有限责任公司 (中国吉林省长春市高新区越达路1718号) filed a patent application (PCT/CN2024/106418) for "FIBROBLAST GROWTH FACTOR RECEPTOR INHIBITOR, PHARMACEUTICAL COMPOSITION AND USE THEREOF" on Jul 19, 2024. With publication no. WO/2025/021033, the details related to the patent application was published on Jan 30, 2025.

Notably, the patent application was submitted under the International Patent Classification (IPC) system, which is ...